Dr Jessica Kaye Cewe, DO | |
910 W 5th Ave Ste 300, Spokane, WA 99204 | |
(509) 838-2531 | |
(509) 755-6580 |
Full Name | Dr Jessica Kaye Cewe |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 11 Years |
Location | 910 W 5th Ave Ste 300, Spokane, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1891135158 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 5101020627 (Michigan) | Secondary |
207V00000X | Obstetrics & Gynecology | OP60747716 (Washington) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Multicare Health System | 7719899897 | 1704 |
News Archive
Researchers at the University of Maryland School of Medicine Center for Vaccine Development (CVD) have charted the extreme genetic differences that occur over time in the most dangerous malaria parasite in the world. While there is no approved vaccine for malaria, various experimental vaccines are in development.
Takeda Pharmaceuticals North America, Inc. announced today that KAPIDEX™ (dexlansoprazole) will be marketed in the United States under the new product trade name DEXILANT™ (dexlansoprazole). The product is indicated for heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE.
What's bugging you now that spring is here? Probably the same thing that's bugging your child -– mosquitoes, ticks and other flying, crawling, or creeping creatures of the great outdoors. Not only are these bugs' bites and stings painful and itchy, the potential health risk of insect-borne diseases - such as Lyme disease and West Nile virus
NPR's "Shots" blog reports on the results of a "high-visibility pilot project to vaccinate 100,000 Haitians against cholera." The blog writes, "Almost 90 percent of the target population - half in Port-au-Prince and the other half in a remote rural area - got fully protected against cholera, meaning they got two doses of the oral vaccine."
Researchers have shown that ranibizumab (Lucentis) eye injections, often in combination with laser treatment, result in better vision than laser treatment alone for diabetes-associated swelling of the retina.
› Verified 5 days ago
Entity Name | Multicare Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
Researchers at the University of Maryland School of Medicine Center for Vaccine Development (CVD) have charted the extreme genetic differences that occur over time in the most dangerous malaria parasite in the world. While there is no approved vaccine for malaria, various experimental vaccines are in development.
Takeda Pharmaceuticals North America, Inc. announced today that KAPIDEX™ (dexlansoprazole) will be marketed in the United States under the new product trade name DEXILANT™ (dexlansoprazole). The product is indicated for heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE.
What's bugging you now that spring is here? Probably the same thing that's bugging your child -– mosquitoes, ticks and other flying, crawling, or creeping creatures of the great outdoors. Not only are these bugs' bites and stings painful and itchy, the potential health risk of insect-borne diseases - such as Lyme disease and West Nile virus
NPR's "Shots" blog reports on the results of a "high-visibility pilot project to vaccinate 100,000 Haitians against cholera." The blog writes, "Almost 90 percent of the target population - half in Port-au-Prince and the other half in a remote rural area - got fully protected against cholera, meaning they got two doses of the oral vaccine."
Researchers have shown that ranibizumab (Lucentis) eye injections, often in combination with laser treatment, result in better vision than laser treatment alone for diabetes-associated swelling of the retina.
› Verified 5 days ago
Entity Name | Rockwood Clinic Ps |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417953787 PECOS PAC ID: 8527976513 Enrollment ID: O20031117000912 |
News Archive
Researchers at the University of Maryland School of Medicine Center for Vaccine Development (CVD) have charted the extreme genetic differences that occur over time in the most dangerous malaria parasite in the world. While there is no approved vaccine for malaria, various experimental vaccines are in development.
Takeda Pharmaceuticals North America, Inc. announced today that KAPIDEX™ (dexlansoprazole) will be marketed in the United States under the new product trade name DEXILANT™ (dexlansoprazole). The product is indicated for heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE.
What's bugging you now that spring is here? Probably the same thing that's bugging your child -– mosquitoes, ticks and other flying, crawling, or creeping creatures of the great outdoors. Not only are these bugs' bites and stings painful and itchy, the potential health risk of insect-borne diseases - such as Lyme disease and West Nile virus
NPR's "Shots" blog reports on the results of a "high-visibility pilot project to vaccinate 100,000 Haitians against cholera." The blog writes, "Almost 90 percent of the target population - half in Port-au-Prince and the other half in a remote rural area - got fully protected against cholera, meaning they got two doses of the oral vaccine."
Researchers have shown that ranibizumab (Lucentis) eye injections, often in combination with laser treatment, result in better vision than laser treatment alone for diabetes-associated swelling of the retina.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jessica Kaye Cewe, DO Po Box 3649, Spokane, WA 99220-3649 Ph: (509) 838-2531 | Dr Jessica Kaye Cewe, DO 910 W 5th Ave Ste 300, Spokane, WA 99204 Ph: (509) 838-2531 |
News Archive
Researchers at the University of Maryland School of Medicine Center for Vaccine Development (CVD) have charted the extreme genetic differences that occur over time in the most dangerous malaria parasite in the world. While there is no approved vaccine for malaria, various experimental vaccines are in development.
Takeda Pharmaceuticals North America, Inc. announced today that KAPIDEX™ (dexlansoprazole) will be marketed in the United States under the new product trade name DEXILANT™ (dexlansoprazole). The product is indicated for heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE.
What's bugging you now that spring is here? Probably the same thing that's bugging your child -– mosquitoes, ticks and other flying, crawling, or creeping creatures of the great outdoors. Not only are these bugs' bites and stings painful and itchy, the potential health risk of insect-borne diseases - such as Lyme disease and West Nile virus
NPR's "Shots" blog reports on the results of a "high-visibility pilot project to vaccinate 100,000 Haitians against cholera." The blog writes, "Almost 90 percent of the target population - half in Port-au-Prince and the other half in a remote rural area - got fully protected against cholera, meaning they got two doses of the oral vaccine."
Researchers have shown that ranibizumab (Lucentis) eye injections, often in combination with laser treatment, result in better vision than laser treatment alone for diabetes-associated swelling of the retina.
› Verified 5 days ago
Karla E Khan, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 235 E Rowan Ave, Ste 102, Spokane, WA 99207 Phone: 509-489-2101 Fax: 509-462-4949 | |
Dr. Craig M. Smentek, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 32 W 2nd Ave, Spokane, WA 99201 Phone: 509-626-9825 Fax: 509-227-7070 | |
Casey Hay, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 W 8th Ave Ste 1400, Spokane, WA 99204 Phone: 509-474-2200 Fax: 509-474-2737 | |
Dr. Dawn Michelle Kopp, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 W 8th Ave Ste 1100, Spokane, WA 99204 Phone: 509-474-4060 Fax: 509-227-7070 | |
Kristian Enghusen, OMS IV Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 322 W North River Dr, Spokane, WA 99201 Phone: 509-324-6464 Fax: 509-241-2056 | |
Dr. Abigail Rose Prest, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 212 E Central Ave Ste 340, Spokane, WA 99208 Phone: 509-484-1236 | |
Mr. Robert F Sestero, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 820 S Mcclellan St, #116, Spokane, WA 99204 Phone: 509-838-4211 Fax: 509-838-6432 |